3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hypertension
3
Diabetes Mellitus, Type 2
3
Cushing Syndrome
3
ACTH Syndrome, Ectopic
3
Pituitary ACTH Hypersecretion
2
Pancreatic Neoplasms
2
Triple Negative Breast Neoplasms
1
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Adrenocortical Carcinoma
1
Adrenal Cortex Neoplasms
1
Interventions
Gemcitabine
14
Cisplatin
13
Capecitabine
11
Paclitaxel
9
Oxaliplatin
9
Fluorouracil
9
130-nm albumin-bound paclitaxel
9
pembrolizumab
7
Albumin-Bound Paclitaxel
7
Ramucirumab
6
Leucovorin
6
Carboplatin
6
Bevacizumab
6
Nivolumab
5
Irinotecan
5
Docetaxel
5
Pemetrexed
4
Everolimus
4
Erlotinib Hydrochloride
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
Radiotherapy
3
Afatinib
3
zolbetuximab
2
trifluridine tipiracil drug combination
2
regorafenib
2
pralsetinib
2
cabozantinib
2
Trastuzumab
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
relacorilant
×
Clear all
No trials found.